Variable n (%) M (SD) Range
Age upon enrollment (years) 10.7 (2.97) 5–17
Age at diagnosis (years) 5.6 (4.07) 1–17
Biological sex (females) 8 (44%)
Treatment status Treatment status Treatment status Treatment status
Current treatment (patient) 5 (27.8%)
Past treatment (survivor) 13 (72.2%)
Cancer diagnosis Cancer diagnosis Cancer diagnosis Cancer diagnosis
Acute lymphoblastic leukemia (ALL) 12 (66.4%)
Acute promyelocytic leukemia (APML) 1 (5.6%)
B-cell lymphoma 1 (5.6%)
Neuroblastoma 1 (5.6%)
Wilms Tumor 1 (5.6%)
Ewing’s sarcoma 1 (5.6%)
Juvenile myelomonocytic leukemia (JMML) 1 (5.6%)
Race/ethnicity
White, Non-Hispanic 10 (55.5%)
White, Hispanic 1 (5.6%)
Black American, Non-Hispanic 4 (22.2%)
Other 2 (11.1%)
Not reported 1 (5.6%)
Annual household income
$0-10,000 1 (5.6%)
$10,000-20,000 1 (5.6%)
$20,000-30,000 2 (11.1%)
$30,000-40,000 3 (16.6%)
$40,000-50,000 3 (16.6%)
$50,000-60,000 0 (0%)
$60,000-80,000 3 (16.6%)
$80,000-100,000 1 (5.6%)
$100,000-120,000 2 (11.1%)
$120,000-140,000 1 (5.6%)
Not reported 1 (5.6%)
Baseline posttraumatic stress symptoms (PTSS) 17.37 (14.56) 3-64
Re-experiencing PTSS 4.22 (4.89) 0-19
Avoidance PTSS 2.11 (2.52) 0-7
Negative affect PTSS 4.11 (5.13) 0-22
Hyperarousal PTSS 5 (4.22) 0-16